These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 5056661)

  • 21. [Esophageal mucosal lesions and scleroderma: prevalence, symptoms and risk factors].
    De Castro Parga ML; Alonso P; García Porrua C; Prada JI
    Rev Esp Enferm Dig; 1996 Feb; 88(2):93-8. PubMed ID: 8664079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progressive systemic sclerosis: radionuclide esophageal scintigraphy and manometry.
    Drane WE; Karvelis K; Johnson DA; Curran JJ; Silverman ED
    Radiology; 1986 Jul; 160(1):73-6. PubMed ID: 3715047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine and systemic scleroderma.
    Goldberg NC; Duncan SC; Winkelmann RK
    Arch Dermatol; 1978 Apr; 114(4):550-1. PubMed ID: 646367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
    Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
    Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
    Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
    Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease.
    Weihrauch TR; Korting GW
    Br J Dermatol; 1982 Sep; 107(3):325-32. PubMed ID: 7115611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cholinergic stimulation on human esophageal peristalsis.
    Hollis JB; Castell DO
    J Appl Physiol; 1976 Jan; 40(1):40-3. PubMed ID: 1248980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multivariate analysis as a method of determination of anthropogenic load on the course of Raynaud's disease in patients with systemic scleroderma and systemic lupus erythematosus].
    Kuchma GB; Bagirova VV; Setko NP
    Ter Arkh; 2001; 73(5):37-9. PubMed ID: 11517745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The natural course of Raynaud's phenomenon].
    Clavijo F; Krahenbuhl B
    Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).
    Follansbee WP; Miller TR; Curtiss EI; Orie JE; Bernstein RL; Kiernan JM; Medsger TA
    J Rheumatol; 1990 May; 17(5):656-62. PubMed ID: 2359076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
    Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
    Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esophageal hypomotility in primary and secondary Raynaud's phenomenon: comparison of esophageal scintigraphy with manometry.
    Limburg AJ; Beekhuis H; Smit AJ; Kallenberg CG; Piers DA; Kleibeuker JH
    J Nucl Med; 1995 Mar; 36(3):451-5. PubMed ID: 7884508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre.
    Lepri G; Guiducci S; Bellando-Randone S; Giani I; Bruni C; Blagojevic J; Carnesecchi G; Radicati A; Pucciani F; Marco MC
    Ann Rheum Dis; 2015 Jan; 74(1):124-8. PubMed ID: 24130266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.